PetIQ (PETQ)
(Delayed Data from NSDQ)
$30.55 USD
+0.03 (0.10%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $30.55 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$30.55 USD
+0.03 (0.10%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $30.55 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Zacks News
Perrigo (PRGO) Rises on Stellar Q419 Preliminary Results
by Zacks Equity Research
Perrigo (PRGO) announces better-than-expected preliminary results for fourth-quarter 2019 as well as the full year. Shares gain.
Perrigo (PRGO) Beats on Q3 Earnings, Tightens '19 EPS View
by Zacks Equity Research
Perrigo (PRGO) reports mixed third-quarter 2019 results. The Rx segment continues to witness recovery. Stock down.
What's in the Cards for Perrigo (PRGO) This Earnings Season?
by Zacks Equity Research
Perrigo's (PRGO) Consumer Self Care Americas segment is expected to have aided the company's top line in the soon-to-be reported quarter.
Analysts Estimate PetIQ (PETQ) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PETQ vs. BSX: Which Stock Is the Better Value Option?
by Zacks Equity Research
PETQ vs. BSX: Which Stock Is the Better Value Option?
Zacks.com featured highlights include: Columbia Sportswear, KLA, Funko, Matrix Service and PetIQ
by Zacks Equity Research
Zacks.com featured highlights include: Columbia Sportswear, KLA, Funko, Matrix Service and PetIQ
5 Profitable Stocks Boasting Amazingly High Net Income Ratio
by Nitish Marwah
Profitability analysis is considered one of the best possible ways to assess the prospects of a company.
Zacks.com featured highlights include: ACM, FibroGen, Funko, Matrix Service and PetIQ
by Zacks Equity Research
Zacks.com featured highlights include: ACM, FibroGen, Funko, Matrix Service and PetIQ
5 Stocks with High Net Income Ratio to Grab Now
by Nitish Marwah
Investors always have a keen eye for companies having a high level of profitability regardless of the market condition.
Perrigo (PRGO) Beats on Q2 Earnings and Sales, Stock Up
by Zacks Equity Research
Perrigo (PRGO) reports encouraging second-quarter 2019 results. The Rx segment recovers on strong new product sales.
PetIQ (PETQ) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
PetIQ (PETQ) delivered earnings and revenue surprises of 150.00% and 13.82%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Perrigo (PRGO) This Earnings Season?
by Zacks Equity Research
Perrigo (PRGO) is focused on Consumer Self Care Americas segment. It remains to be seen if this benefits the company's results in the soon-to-be reported quarter.
Perrigo Completes Ranir Acquisition, Raises '19 Guidance
by Zacks Equity Research
Perrigo (PRGO) completes previously announced acquisition of Ranir. The company raised guidance for adjusted earnings to include accretion of 10 cents from Ranir.
Perrigo (PRGO) Beats on Q1 Earnings and Sales, Stock Up
by Zacks Equity Research
Perrigo (PRGO) reports encouraging first-quarter 2019 results. The Rx segment recovers during the quarter on strong new product sales.
Analysts Estimate PetIQ (PETQ) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PetIQ (PETQ) Misses Q4 Earnings Estimates
by Zacks Equity Research
PetIQ (PETQ) delivered earnings and revenue surprises of -14.29% and 12.46%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
PetIQ (PETQ) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
PetIQ (PETQ) delivered earnings and revenue surprises of 88.00% and 5.03%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate PetIQ (PETQ) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PetIQ (PETQ) Q3 Earnings Preview: What to Watch Ahead of the Release
by Zacks Equity Research
PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ABT or PETQ: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ABT vs. PETQ: Which Stock Is the Better Value Option?
PetIQ (PETQ) Catches Eye: Stock Jumps 9.1%
by Zacks Equity Research
PetIQ (PETQ) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.